muscular dystrophy

DEFINITION of muscular dystrophy

Muscular dystrophy (MD) encompasses a heterogeneous group of more than 30 inherited, progressive neuromuscular disorders characterized by a fundamental genetic defect that impairs the body’s ability to produce structurally essential muscle proteins. The most common and severe phenotype is Duchenne muscular dystrophy (DMD), an X-linked recessive condition caused by an absence of dystrophin, a critical protein that connects the cytoskeleton of a muscle fiber to the surrounding extracellular matrix. Without dystrophin, muscle fibers undergo continuous damage during contraction, eventually being replaced by fat and fibrotic tissue (presenting clinically as calf pseudohypertrophy). Patients typically present in early childhood with delayed motor milestones, a waddling gait, and a positive Gowers’ sign (using hands to “walk up” the legs to stand). Becker muscular dystrophy (BMD) is a milder variant where dystrophin is partially functional. Other major forms include Myotonic dystrophy (characterized by delayed muscle relaxation/myotonia and multisystemic involvement), Facioscapulohumeral (FSHD), and Limb-girdle (LGMD) dystrophies. As the disease progresses, it inevitably leads to profound mobility loss, wheelchair dependence, and life-threatening respiratory and cardiac complications (cardiomyopathy). Clinical Indicators: For coding purposes, exact phenotyping is required. Look for documentation confirming the specific variant (e.g., Duchenne, Becker, Myotonic), elevated Creatine Kinase (CK) levels, and confirmatory genetic testing or muscle biopsy results.

---

ETYMOLOGY of muscular dystrophy

latin greek

Component	Origin	Meaning
muscul-	Latin musculus	”Little mouse / muscle” — ancient anatomists thought the rippling of muscles beneath the skin resembled mice running; refers to the affected tissue type
dys-	Ancient Greek δυσ- (dys-)	“Bad, difficult, abnormal, disordered” — indicates a pathological defect; appears in dysphagia, dyskinesia
troph-	Ancient Greek τροφή (trophē)	“Nourishment, growth” — refers to the development and maintenance of the tissue; appears in atrophy, hypertrophy
-y	Latin/Greek -ia / -y	Noun suffix — “condition or state of”

Literally: “Condition of abnormal muscle growth/nourishment.” While the condition is fundamentally a structural protein defect rather than a “nourishment” issue, the historical terminology reflects the macroscopic observation of the muscles wasting away (atrophy) or appearing falsely enlarged (pseudohypertrophy) due to the underlying disease process.

---

🔀 ALIASES / ALTERNATE TERMS

• MD (universal clinical abbreviation)
• DMD (Duchenne muscular dystrophy — the most common and severe pediatric form)
• BMD (Becker muscular dystrophy — a milder, slower-progressing variant of DMD)
• Myotonic dystrophy / Steinert’s disease (the most common adult-onset form; uniquely features delayed muscle relaxation/myotonia)
• FSHD (Facioscapulohumeral muscular dystrophy — primarily affects the face, shoulder blades, and upper arms)
• LGMD (Limb-girdle muscular dystrophy — affects the proximal muscles of the hips and shoulders)

---

🔗 RELATED TERMS

• Dystrophin — the specific structural protein missing in DMD and altered in BMD; normally protects muscle fibers from contraction-induced injury.
• Gowers’ sign — a classic clinical finding in pediatric DMD where a child has to use their hands and arms to “walk” up their own body from a squatting position due to severe proximal pelvic weakness.
• Pseudohypertrophy — the false enlargement of muscles (classically the calves in DMD); the muscle looks hypertrophic but is actually filled with fat and scar tissue.
• Atrophy — M62.50; the true wasting away or decrease in size of muscle tissue.
• Creatine Kinase (CK) — R79.89; an enzyme leaked by damaged muscle cells; massively elevated in early DMD (often $>10,000$ U/L) and used as a primary diagnostic marker.
• Cardiomyopathy — I43; disease of the heart muscle; a common, life-limiting complication of progressive muscular dystrophies.
• Spinal Muscular Atrophy (SMA) — G12.9; another progressive pediatric neuromuscular disease, but caused by anterior horn motor neuron loss rather than primary muscle cell defects.

---

CODING CORNER

🏥 ICD-10-CM CODES

Primary Diagnosis — Muscular Dystrophy (Category G71.0-)

(Under Chapter 6: Diseases of the Nervous System. Subcategory G71.0 requires phenotypical specificity. Do NOT use the parent code G71.0.)

Code	Description
G71.01	Duchenne or Becker muscular dystrophy (The primary code for dystrophinopathies)
G71.02	Facioscapulohumeral muscular dystrophy
G71.11	Myotonic muscular dystrophy (Steinert’s disease)
G71.031	Autosomal dominant limb girdle muscular dystrophy
G71.09	Other specified muscular dystrophies

Associated Manifestations & Complications

(Frequently required to capture the systemic severity of advanced MD)

Code	Description
I43	Cardiomyopathy in diseases classified elsewhere (Code first the underlying MD [e.g., G71.01] if the patient has MD-associated cardiac involvement)
J96.10	Chronic respiratory failure, unspecified whether with hypoxia or hypercapnia (Common in late-stage MD; requires mechanical ventilation)
Z99.11	Dependence on respirator [ventilator] status
R26.2	Difficulty in walking, not elsewhere classified (Waddling gait)

---

🔧 COMMON CPT CODES (Diagnostics & Management)

Diagnostic Evaluation

(Historically diagnosed via biopsy and EMG; modern diagnosis relies heavily on genetic testing)

CPT Code	Description
81161	DMD (dystrophin) (e.g., Duchenne/Becker muscular dystrophy) gene analysis; full gene sequence (The gold-standard confirmatory blood test)
20200	Biopsy, muscle; superficial (Used when genetic testing is inconclusive or to assess specific protein expression via immunostaining)
20205	Biopsy, muscle; deep
95860	Needle electromyography; one extremity with or without related paraspinal areas (Differentiates primary muscle disease/myopathy from nerve disease/neuropathy)

Physical Therapy & Rehabilitation

(Critical for maintaining range of motion, preventing contractures, and optimizing function)

CPT Code	Description
97110	Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility
97112	Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities

Modifiers Commonly Used

Modifier	Usage
-26	Professional component — Append to the EMG code (95860) if the neurologist performs and interprets the test using the hospital’s or facility’s equipment.
-LT / -RT	Left side / Right side — Used on muscle biopsy surgical codes (20200, 20205) to designate the laterality of the tissue sampling.

---

⚠️ Coding Note: The most critical aspect of coding muscular dystrophy is pushing for exact genetic phenotype documentation. Never settle for the generalized term “muscular dystrophy” if the chart contains genetic testing results or clinical history defining it as Duchenne, Becker, or Myotonic; you must drill down to the valid, billable codes (G71.01, G71.11, etc.). Furthermore, advanced MD is a multisystem disease. If a patient is admitted for respiratory failure or heart failure stemming from their MD, you must sequence the diagnoses according to the circumstances of the admission, often using the “code first underlying disease” rule (e.g., G71.01 followed by I43 for cardiomyopathy). When billing muscle biopsies, verify whether the procedure was superficial vs. deep, as this dictates the CPT selection.

---

DERIVATIONS of muscular dystrophy

TABLE definition AS Definition
FROM #medterm
WHERE length(filter(roots, (word) => econtains([[muscular dystrophy]].roots, word))) > 0 AND file.name != [[muscular dystrophy]].file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE file.name != this.file.name
AND any(contains(this.definition, definition))

Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms